Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

I. Vicenti · SciRah

Researcher profile · Semantic Scholar

I. Vicenti

Share profile

I. Vicenti — researcher profile on SciRah

h-index: 21
Works: 105
Citations: 1,400

Most-cited papers

SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
I. Vicenti, M. Zazzi, F. Saladini
2021Expert Opinion on Therapeutic Patents110 citations Open access
Semantic Scholar
Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge
Francesca Picarazzi, I. Vicenti, F. Saladini, M. Zazzi +1 more
2020Molecules92 citations Open access
Semantic Scholar
Changing patterns in HIV‐1 non‐B clade prevalence and diversity in Italy over three decades *
Alessia Lai, Chiara Riva, A. Marconi, M. Balestrieri +13 more
2010HIV Medicine63 citations Open access
Semantic Scholar
Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy.
I. Vicenti, Andrea Rosi, F. Saladini, G. Meini +8 more
2012Journal of Antimicrobial Chemotherapy61 citations Open access
Semantic Scholar
Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic
A. Lai, A. Bergna, S. Caucci, N. Clementi +16 more
2020medRxiv54 citations Open access
Semantic Scholar
Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro.
I. Vicenti, A. Boccuto, Alessia Giannini, Filippo Dragoni +2 more
2018Virus Research46 citations
Semantic Scholar
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors
A. De Luca, S. Di Giambenedetto, Alessandra Lo Presti, S. Sierra +16 more
2015Open Forum Infectious Diseases43 citations Open access
Semantic Scholar
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro.
Filippo Dragoni, A. Boccuto, Francesca Picarazzi, Alessia Giannini +6 more
2020Antiviral Research42 citations Open access
Semantic Scholar
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro
A. Gidari, S. Sabbatini, E. Schiaroli, Sabrina Bastianelli +9 more
2022Microorganisms41 citations Open access
Semantic Scholar
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021
Alessia Lai, A. Bergna, S. Menzo, G. Zehender +35 more
2021Virology Journal37 citations Open access
Semantic Scholar
Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose
I. Vicenti, M. Basso, F. Gatti, R. Scaggiante +6 more
2021International Journal of Infectious Diseases34 citations Open access
Semantic Scholar
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.
M. Zazzi, M. Prosperi, I. Vicenti, S. Di Giambenedetto +11 more
2009Journal of Antimicrobial Chemotherapy34 citations Open access
Semantic Scholar
SARS-CoV-2 Infection of Human Ovarian Cells: A Potential Negative Impact on Female Fertility
F. P. Luongo, Filippo Dragoni, A. Boccuto, E. Paccagnini +7 more
2022Cells31 citations Open access
Semantic Scholar
Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection
I. Vicenti, F. Gatti, R. Scaggiante, A. Boccuto +5 more
2021International Journal of Infectious Diseases29 citations Open access
Semantic Scholar
Zika Virus in West Africa: A Seroepidemiological Study between 2007 and 2012
S. Marchi, S. Viviani, E. Montomoli, Yu-Xiao Tang +8 more
2020Viruses27 citations Open access
Semantic Scholar
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
Lia Fiaschi, Camilla Biba, Ilenia Varasi, N. Bartolini +5 more
2024Viruses25 citations Open access
Semantic Scholar
Bithiazole Inhibitors of Phosphatidylinositol 4‐Kinase (PI4KIIIβ) as Broad‐Spectrum Antivirals Blocking the Replication of SARS‐CoV‐2, Zika Virus, and Human Rhinoviruses
Maria Grazia Martina, I. Vicenti, Lisa Bauer, Emmanuele Crespan +12 more
2021ChemMedChem23 citations Open access
Semantic Scholar
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
Lia Fiaschi, Filippo Dragoni, E. Schiaroli, A. Bergna +9 more
2022Viruses22 citations Open access
Semantic Scholar
Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors.
R. Scutari, C. Alteri, I. Vicenti, D. Di Carlo +11 more
2020Journal of Global Antimicrobial Resistance21 citations Open access
Semantic Scholar
Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV‐1 protease, reverse transcriptase, and integrase inhibitors
F. Saladini, Alessia Giannini, A. Boccuto, I. Vicenti +1 more
2018Journal of clinical laboratory analysis (Print)21 citations Open access
Semantic Scholar
Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses.
María Del Rosario García-Lozano, Filippo Dragoni, P. Gallego, S. Mazzotta +10 more
2023Bioorganic chemistry (Print)19 citations Open access
Semantic Scholar
Prevalence and determinants of resistance mutations in HIV‐1‐infected patients exposed to integrase inhibitors in a large Italian cohort
S. Modica, B. Rossetti, F. Lombardi, F. Lagi +13 more
2018HIV Medicine19 citations
Semantic Scholar
In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study
Damiano Cirri, T. Marzo, Iogann Tolbatov, A. Marrone +5 more
2021Biomolecules18 citations Open access
Semantic Scholar
The prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients.
R. Ungaro, L. Taramasso, B. Bruzzone, I. Vicenti +103 more
2019Clinical Microbiology and Infection18 citations Open access
Semantic Scholar
Comparable In Vitro Activities of Second-Generation HIV-1 Integrase Strand Transfer Inhibitors (INSTIs) on HIV-1 Clinical Isolates with INSTI Resistance Mutations
F. Saladini, Alessia Giannini, A. Boccuto, Filippo Dragoni +4 more
2019Antimicrobial Agents and Chemotherapy18 citations Open access
Semantic Scholar
Exploring the Implication of DDX3X in DENV Infection: Discovery of the First-in-Class DDX3X Fluorescent Inhibitor.
A. Brai, A. Boccuto, M. Monti, S. Marchi +13 more
2020ACS Medicinal Chemistry Letters17 citations Open access
Semantic Scholar
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication
I. Vicenti, Filippo Dragoni, Alessia Giannini, Federica Giammarino +4 more
2020SLAS discovery : advancing life sciences R & D16 citations Open access
Semantic Scholar
The second dose of the BNT162b2 mRNA vaccine does not boost SARS-CoV-2 neutralizing antibody response in previously infected subjects
I. Vicenti, F. Gatti, R. Scaggiante, A. Boccuto +5 more
2021Infection15 citations Open access
Semantic Scholar
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
F. Saladini, Federica Giammarino, Behnaz-Alsadat Hosseini, Alessia Giannini +5 more
2020Journal of Antimicrobial Chemotherapy15 citations Open access
Semantic Scholar
Epidemiological and Clinical Features of SARS-CoV-2 Variants Circulating between April–December 2021 in Italy
Alessia Lai, A. Bergna, C. Della Ventura, S. Menzo +46 more
2022Viruses14 citations Open access
Semantic Scholar
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2
I. Vicenti, Maria Grazia Martina, A. Boccuto, Marta De Angelis +12 more
2021European Journal of Medicinal Chemistry14 citations Open access
Semantic Scholar
A unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses.
V. Riva, A. Garbelli, A. Brai, F. Casiraghi +11 more
2020Journal of Medicinal Chemistry14 citations Open access
Semantic Scholar
The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro
F. Saladini, Alessia Giannini, A. Boccuto, D. Tiezzi +2 more
2017AIDS (London)14 citations
Semantic Scholar
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood
I. Vicenti, G. Meini, F. Saladini, Alessia Giannini +3 more
2017Clinical Chemistry and Laboratory Medicine13 citations
Semantic Scholar
Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients
C. Trombetta, S. Marchi, S. Viviani, A. Manenti +6 more
2021Viruses12 citations Open access
Semantic Scholar
Pretreatment HIV drug Resistance and Treatment Failure in Non-Italian HIV-1-Infected Patients Enrolled in ARCA
D. Bavaro, D. Di Carlo, B. Rossetti, B. Bruzzone +11 more
2020Antiviral Therapy12 citations Open access
Semantic Scholar
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity
S. Cesarini, I. Vicenti, F. Poggialini, M. Secchi +8 more
2022Molecules11 citations Open access
Semantic Scholar
Comparison of Different HIV-1 Resistance Interpretation Tools for Next-Generation Sequencing in Italy
D. Armenia, L. Carioti, V. Micheli, I. Bon +21 more
2024Viruses9 citations Open access
Semantic Scholar
External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
I. Vicenti, Filippo Dragoni, Alessia Giannini, A. Casabianca +33 more
2022Scientific Reports9 citations Open access
Semantic Scholar
Cellular and Molecular Mechanisms of In Vivo and In Vitro SARS-CoV-2 Infection: A Lesson from Human Sperm
A. Luddi, F. P. Luongo, Filippo Dragoni, Lia Fiaschi +9 more
2022Cells9 citations Open access
Semantic Scholar
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization.
Anna Bonomini, Tommaso Felicetti, Martina Pacetti, Chiara Bertagnin +14 more
2024European journal of medicinal chemistry8 citations Open access
Semantic Scholar
No impact of previous NRTIs resistance in HIV positive patients switched to DTG+2NRTIs under virological control: Time of viral suppression makes the difference.
A. Giacomelli, A. Lai, M. Franzetti, F. Maggiolo +11 more
2019Antiviral Research8 citations Open access
Semantic Scholar
The HIV-1 reverse transcriptase E138A natural polymorphism decreases the genetic barrier to resistance to etravirine in vitro
Alessia Giannini, I. Vicenti, Angelo Materazzi, A. Boccuto +3 more
2018Journal of Antimicrobial Chemotherapy8 citations Open access
Semantic Scholar
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines.
Martina Pacetti, M. C. Pismataro, Tommaso Felicetti, Federica Giammarino +11 more
2024Organic and biomolecular chemistry7 citations Open access
Semantic Scholar
Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy’s outcome for HIV-1
Giulia Di Teodoro, M. Pirkl, F. Incardona, I. Vicenti +5 more
2023Bioinform.7 citations Open access
Semantic Scholar
Phylogeography and genomic epidemiology of SARS-CoV-2 in Italy and Europe with newly characterized Italian genomes between February-June 2020
A. Lai, A. Bergna, S. Toppo, Marina Morganti +104 more
2022Scientific Reports7 citations Open access
Semantic Scholar
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies
Filippo Dragoni, E. Schiaroli, V. Micheli, Lia Fiaschi +7 more
2022Clinical Microbiology and Infection6 citations Open access
Semantic Scholar
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells.
I. Vicenti, Filippo Dragoni, M. Monti, C. Trombetta +11 more
2020Journal of General Virology6 citations Open access
Semantic Scholar
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database.
R. Rossotti, V. Borghi, A. Callegaro, V. Micheli +7 more
2016Journal of Clinical Virology6 citations
Semantic Scholar
Frequent Detection of Antiretroviral Drug Resistance in HIV-1-Infected Orphaned Children Followed at a Donor-Funded Rural Pediatric Clinic in Dodoma, Tanzania
G. Meini, M. Balestrieri, S. Cianchino, D. Tacconi +7 more
2015AIDS Research and Human Retroviruses6 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Zazzi×34
Invite
M. Zazzi — researcher profile on SciRah
F. Saladini×22
Invite
F. Saladini — researcher profile on SciRah
Filippo Dragoni×21
Invite
Filippo Dragoni — researcher profile on SciRah
A. Boccuto×21
Invite
A. Boccuto — researcher profile on SciRah

Alessia Giannini

×11

Invite

Alessia Giannini — researcher profile on SciRah

Federica Giammarino×8

Invite

Federica Giammarino — researcher profile on SciRah

D. Francisci×8

Invite

D. Francisci — researcher profile on SciRah

Invite

B. Bruzzone — researcher profile on SciRah

Invite

B. Rossetti — researcher profile on SciRah

S. Di Giambenedetto×7

Invite

S. Di Giambenedetto — researcher profile on SciRah

Invite

A. De Luca — researcher profile on SciRah

Invite

A. Lai — researcher profile on SciRah